CLEANSTART
Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 24 Sept 2025)
What this means for you
Registered since 11 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87812849
- Registration number
- 5625919
- Mark type
- Stylized text
- Filed
- 27 Feb 2018
- Published for opposition
- 25 Sept 2018
- Registered
- 11 Dec 2018
- Attorney of record
- Daniel M. Gurfinkel
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; kits comprising chemicals for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning
- Class 005 — Pharmaceuticals: [ Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; kits containing preparations for medical and veterinary diagnostic purposes, in particular for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning ]
Owner
- QIAGEN GmbH, Hilden, DE
- QIAGEN GmbH, Hilden, DE
- QIAGEN GmbH, Hilden, DE
Prosecution history
- 24 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Sept 2025 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 22 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 May 2025 — TEAS SECTION 8 & 15 RECEIVED
- 11 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 May 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 25 Sept 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Sept 2018 — PUBLISHED FOR OPPOSITION
- 05 Sept 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Aug 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Aug 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Aug 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Aug 2018 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 21 Aug 2018 — USE AMENDMENT ACCEPTED